Eikon Therapeutics, Inc. Common Stock (EIKN) — Long-term Investment Intensity
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Long-term Investment Intensity of 9.9% as of March 2026. Long-term investments of $83.83 Million represent 9.9% of total assets of $850.83 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. For the complete balance sheet picture, see Eikon Therapeutics, Inc. Common Stock total assets.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Eikon Therapeutics, Inc. Common Stock (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Eikon Therapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read EIKN current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|